Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review

被引:26
作者
Draker, Nicole [1 ]
Torry, Donald S. [2 ]
Torry, Ronald J. [1 ]
机构
[1] Drake Univ, Dept Pharmaceut & Adm Sci, Ellis Pharmacogen Lab, Coll Pharm & Hlth Sci, Des Moines, IA 50311 USA
[2] Southern Illinois Univ, Sch Med, Dept OB GYN, Dept Med Microbiol Immunol & Cell Biol, Springfield, IL 62702 USA
关键词
biomarkers; coronary artery disease; diagnosis; heart failure; placenta growth factor; PlGF; prognosis; sFlt-1; soluble fms-like tyrosine kinase receptor-1; TYROSINE KINASE 1; CORONARY MICROVASCULAR DYSFUNCTION; PRESERVED EJECTION FRACTION; CARDIAC BIOMARKERS; ENDOTHELIAL-CELLS; FACTOR EXPRESSION; FACTOR RECEPTOR-1; ADVERSE OUTCOMES; SERUM-LEVELS; CARDIOVASCULAR EVENTS;
D O I
10.2217/bmm-2018-0492
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Coronary heart disease (CHD) and heart failure (HF) produce significant morbidity/mortality but identifying new biomarkers could help in the management of each. In this article, we summarize the molecular regulation and biomarker potential of PIGF and sFlt-1 in CHD and HF. PlGF is elevated during ischemia and some studies have shown PlGF, sFlt-1 or PlGF: sFlt-1 ratio, when used in combination with standard biomarkers, strengthens predictions of outcomes. sFlt-1 and PlGF are elevated in HF with sFlt-1 as a stronger predictor of outcomes. Although promising, we discuss additional study criteria needed to confirm the clinical usefulness of PlGF or sFlt-1 in the detection and management of CHD or HF.
引用
收藏
页码:785 / 799
页数:15
相关论文
共 112 条
[1]   Placental Growth Factor as a Protective Paracrine Effector in the Heart [J].
Accornero, Federica ;
Molkentin, Jeffery D. .
TRENDS IN CARDIOVASCULAR MEDICINE, 2011, 21 (08) :220-224
[2]   Placental Growth Factor Regulates Cardiac Adaptation and Hypertrophy Through a Paracrine Mechanism [J].
Accornero, Federica ;
van Berlo, Jop H. ;
Benard, Matthew J. ;
Lorenz, John N. ;
Carmeliet, Peter ;
Molkentin, Jeffery D. .
CIRCULATION RESEARCH, 2011, 109 (03) :272-U95
[3]   Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia [J].
Ahmad, S ;
Ahmed, A .
CIRCULATION RESEARCH, 2004, 95 (09) :884-891
[4]   Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome [J].
Apple, Fred S. ;
Pearce, Lesly A. ;
Chung, Adrine ;
Ler, Ranka ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2007, 53 (05) :874-881
[5]   Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 [J].
Autiero, M ;
Waltenberger, J ;
Communi, D ;
Kranz, A ;
Moons, L ;
Lambrechts, D ;
Kroll, J ;
Plaisance, S ;
De Mol, M ;
Bono, F ;
Kliche, S ;
Fellbrich, G ;
Ballmer-Hofer, K ;
Maglione, D ;
Mayr-Beyrle, U ;
Dewerchin, M ;
Dombrowski, S ;
Stanimirovic, D ;
Van Hummelen, P ;
Dehio, C ;
Hicklin, DJ ;
Persico, G ;
Herbert, JM ;
Communi, D ;
Shibuya, M ;
Collen, D ;
Conway, EM ;
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (07) :936-943
[6]   PlGF-MMP9-engineered iPS cells supported on a PEG-fibrinogen hydrogel scaffold possess an enhanced capacity to repair damaged myocardium [J].
Bearzi, C. ;
Gargioli, C. ;
Baci, D. ;
Fortunato, O. ;
Shapira-Schweitzer, K. ;
Kossover, O. ;
Latronico, M. V. G. ;
Seliktar, D. ;
Condorelli, G. ;
Rizzi, R. .
CELL DEATH & DISEASE, 2014, 5 :e1053-e1053
[7]   Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study [J].
Behrens, Ida ;
Basit, Saima ;
Lykke, Jacob A. ;
Ranthe, Mattis F. ;
Wohlfahrt, Jan ;
Bundgaard, Henning ;
Melbye, Mads ;
Boyd, Heather A. .
PLOS ONE, 2019, 14 (02)
[8]  
Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI [10.1161/CIR.0000000000000558, 10.1161/CIR.0000000000000485, 10.1161/CIR.0000000000000530]
[9]   Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model [J].
Binsalamah, Ziyad Mohammed ;
Paul, Arghya ;
Khan, Afshan Afsar ;
Prakash, Satya ;
Shum-Tim, Dominique .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 :2667-2678
[10]   Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial [J].
Bui, An H. ;
Bonaca, Marc P. ;
Sabatine, Marc S. ;
Ray, Kausik K. ;
Rifai, Nader ;
Cannon, Christopher P. ;
Morrow, David A. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (02) :222-228